BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6788942)

  • 21. [Parasitic infections in pregnancy and congenital protozoan infections. Part I.: Protozoan infections].
    Bialek R; Knobloch J
    Z Geburtshilfe Neonatol; 1999; 203(2):55-62. PubMed ID: 10420511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drugs used against protozoan infections in man].
    Takada S
    Nihon Rinsho; 1990 Oct; 48(10):2228-33. PubMed ID: 2280469
    [No Abstract]   [Full Text] [Related]  

  • 24. Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa.
    Howes HL; Lynch JE; Kivlin JL
    Antimicrob Agents Chemother (Bethesda); 1969; 9():261-6. PubMed ID: 5396498
    [No Abstract]   [Full Text] [Related]  

  • 25. The chemotherapy of protozoal infections of veterinary importance.
    Joyner LP
    J Protozool; 1981 Feb; 28(1):17-9. PubMed ID: 7019418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 27. Intestinal parasitic infections.
    Botero D
    Antibiot Chemother (1971); 1981; 30():1-19. PubMed ID: 7259130
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of intestinal parasitic infections: a review of nitazoxanide.
    Gilles HM; Hoffman PS
    Trends Parasitol; 2002 Mar; 18(3):95-7. PubMed ID: 11854075
    [No Abstract]   [Full Text] [Related]  

  • 29. Human antiprotozoal therapy: past, present, and future.
    Khaw M; Panosian CB
    Clin Microbiol Rev; 1995 Jul; 8(3):427-39. PubMed ID: 7553575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined action of pyrimidines and sulfonamides or sulfones in the chemotherapy of malaria and other protozoal infections.
    Richards WH
    Adv Pharmacol Chemother; 1970; 8():121-47. PubMed ID: 5002795
    [No Abstract]   [Full Text] [Related]  

  • 31. Common and uncommon parasitic infections in the United States.
    Tan JS
    Med Clin North Am; 1978 Sep; 62(5):1059-81. PubMed ID: 104098
    [No Abstract]   [Full Text] [Related]  

  • 32. The apicoplast as a potential therapeutic target in and other apicomplexan parasites.
    Soldati D
    Parasitol Today; 1999 Jan; 15(1):5-7. PubMed ID: 10234168
    [No Abstract]   [Full Text] [Related]  

  • 33. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
    Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
    Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis).
    Bouchikhi F; Anizon F; Brun R; Moreau P
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6319-21. PubMed ID: 21937228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of intestinal parasitic diseases].
    Levi GC
    AMB Rev Assoc Med Bras; 1982; 28 Suppl 1():20-4. PubMed ID: 6984969
    [No Abstract]   [Full Text] [Related]  

  • 36. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serological problems in the diagnosis of protozoal diseases (author's transl)].
    Mohr W
    MMW Munch Med Wochenschr; 1974 Aug; 116(34):1459-66. PubMed ID: 4215001
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
    Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
    Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Overview of Drug Resistance in Protozoal Diseases.
    Capela R; Moreira R; Lopes F
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.